Blackwell Publishing

Paracetamol may reduce the risk of ovarian cancer by almost a third

Published in Medical Verdicts and Law Weekly, July 27th, 2006

Using paracetamol regularly could reduce the risk of ovarian cancer by almost a third, according to a detailed analysis in a recent issue of British Journal of Clinical Pharmacology.

A research team from Athens University found that the risk fell by up to 30% when they analyzed the results of major studies carried out on more than 746,000 women over a six-year period.

4,405 of the women in the eight major studies - from the U.S., U.K. and Denmark - had ovarian cancer.

The team looked at all studies covering paracetamol and ovarian cancer from 1966 to 2004. These were then scrutinized using sophisticated meta-analysis...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly

Source: Medical Verdicts and Law Weekly (2006-07-27)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry